COVID-19 increases rate of heart attacks in people at genetic risk for heart disease

heart attack
Credit: CC0 Public Domain

Individuals with genetic high cholesterol, heart disease, or both and who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer outcomes if a person with genetic high cholesterol—called familial hypercholesterolemia (FH)—contracts COVID-19, this study from the FH Foundation's national healthcare database is the first to demonstrate higher heart attack rates in the real world. Published online in the American Journal of Preventive Cardiology, the study also importantly confirms that COVID-19 increases heart attack rates in individuals with established atherosclerotic cardiovascular disease (ASCVD).

The FH Foundation performed an analysis of 55,412,462 individuals, separating groups into six matched cohorts including diagnosed FH, probable FH, and ASCVD, with and without COVID-19 infection (as identified by the U07.1 ICD-10 code). The researchers found that rates of heart attacks were highest in those with a COVID-19 diagnosis and the presence of diagnosed FH or probable FH with known ASCVD.

"These results are significant because these data underscore the importance of understanding if individuals have underlying or genetic high when treating for COVID-19 infection or considering vaccination," said Kelly Myers, study author and chief technology officer of the FH Foundation.

Familial hypercholesterolemia is a common genetic condition that increases an individual's risk for cardiovascular disease by up to 20-fold due to lifelong elevated low density lipoprotein cholesterol (LDL-C) levels. Today, only 10% of the 1.3 million Americans with FH are diagnosed, due to lack of awareness in the medical community and public. To understand the effect of COVID-19 on these individuals, the researchers applied the FIND FH machine learning model on the dataset.

The study findings have important implications for individuals with FH who are not diagnosed today, say the researchers. "Probable FH" individuals with pre-existing ASCVD who contracted COVID had attacks at a seven-times greater annual rate than their counterparts who did not contract the virus (AIDR 15.4% vs 2.1% p-value <0.002).

"The highest rates occurred in individuals infected with COVID-19 who had preexisting cardiovascular disease and were flagged by the FIND FH model as probable FH. We speculate that because these individuals have yet to receive an FH diagnosis, they may not be receiving appropriate lipid-lowering treatment, placing them at significantly higher risk," added Dr. Mary McGowan, study author and chief medical officer for the FH Foundation. "This study is a call to action to diagnose individuals with this deadly genetic condition who are hiding in plain sight within our healthcare system, and take particular precautions related to COVID-19 infections. FH is an untapped opportunity for prevention."

The FH Foundation plans to leverage this and other ongoing research to continue to advocate to prioritize FH as a public health concern.

More information: Kelly D. Myers et al, COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD, American Journal of Preventive Cardiology (2021). DOI: 10.1016/j.ajpc.2021.100197
Provided by The Familial Hypercholesterolemia Foundation
Citation: COVID-19 increases rate of heart attacks in people at genetic risk for heart disease (2021, May 27) retrieved 4 December 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Children with familial hypercholesterolemia are diagnosed late and under-treated


Feedback to editors